1. Details of corporate proposalWhether the corporate proposal involves the issuance of new type and new classof securities? NTypes of corporate proposal : Exercise of WarrantsDetails of corporate proposal : Conversion of Warrants 2018/2021 to OrdinarySharesNo. of shares issued under this corporate proposal : 1,207,600Issue price per share ($$) : 0.0800Par Value ($$) (if applicable) : 0.000Latest issued share capital after the above corporate proposalIn the followingUnits : 476,435,900Issued Share Capital ($$) : Singapore Dollar (SGD) 22,628,921.010Listing Date : 04/11/2020Remarks:You are advised to read the entire contents of the announcement or attachment.To read the entire contents of the announcement or attachment, please accessthe Bursa website at http://www.bursamalaysia.com
Reported in Indonesian newspapers on Halal Cerification.
REPUBLIKA.CO.ID, JAKARTA -- Badan Pengawas Obat dan Makanan (BPOM) memastikan bahwa calon vaksin Covid-19 yang dikerjasamakan oleh Bio Farma dengan Sinopharm, pabrikan farmasi asal China, dan Group 42 asal Uni Emirat Arab (UEA), telah mendapat sertifikat halal. Kandidat vaksin yang sudah dipesan Indonesia sebanyak 10 juta dosis ini juga telah mengantongi izin penggunaan darurat atau 'emergency use authorization' dari regulator pengawas obat China.
Kstar suppy shoes for hospitals worldwide. Disposable inner wear for male and female doctors for 36 on call duty. Fast and steady usage daily for disposable product
Honsin Apparel Sdn. Bhd., a wholly-owned subsidiary of Prolexus Berhad (Prolexus), is registered with the U.S. Food and Drug Administration (FDA) for face mask for general public / healthcare personnel per Immediately in Effect Guidance (IIE Guidance). The registration is expected to expand ProXmask™ export market horizon to the US market to curb Covid-19 pandemic.
Prolexus, which is already an established international sportswear manufacturer, has aggressively responded to the unprecedented pandemic crisis through the development of ProXmask™ as one of its core products. Prolexus aspires to deliver high quality reusable functional fabric mask to ensure effective protection for everyone against the virus.
Prolexus revealed its cutting edge ProX™ anti-virus technology which inactivates bacteria and viruses, including >99% SARS-CoV-2, the virus responsible for Covid-19. The technology, accompanied with its water repellency and microfiltration properties, enables ProXmask™ to be both protective and preventive, benefiting both self and others in close proximity. The absence of self-disinfection property in conventional disposal masks however, increases the risk of disease spread upon improper handling and disposal.
Moreover, the reusability of ProXmask™ makes it an eco-friendly and cost-effective choice. It stays effective up to 60 wash cycles, making it equivalent to at least 120 disposal masks, assuming a 4 to 6 hours of usage lifespan (as doctors' advise) per disposal mask. Its protective features also exceed the ones in disposal masks, making it a value for money product.
ProXmask™ protective features have passed the test conducted by various international accredited laboratories. Backed by its advanced ProX™ anti-virus technology, Prolexus is set to explore innovative market segments such as personal protective apparels, a new emerging sportswear category. Prolexus marketing is actively working towards serving prospective clients with interest in protective and functional activewears.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
puppis
16 posts
Posted by puppis > 2020-11-02 16:14 | Report Abuse
This Stk P&L Negative